Bilateral Thoracic paravertebral block
ProcedureThe blocks were performed at the T3-T4 level bilaterally to block the dermatomes between the T2 and T6 levels (breast innervation area).
Other names: TPVBs
NCT Number: NCT04596787
Aim: Although regional anesthesia (RA) techniques are advantageous in the anesthetic management of obese patients (body mass index (BMI)≥30); their performances can still be associated with technical difficulties and greater failure rates. The aim of this study is to compare the performance properties and analgesic efficacy of ultrasound (US)-guided bilateral thoracic paravertebral blocks (TPVBs) in obese and non-obese patients.
Material methods: After obtaining ethics committee approval; data of 82 patients, who underwent elective bilateral reduction mammaplasty under general anesthesia with adjunctive TPVB analgesia between December of 2016 and February of 2020, were reviewed. Patients were allocated into two groups with respect to their BMI scores (Group NO: BMI<30 and Group O: BMI≥30). Demographics, TPVB ideal US image visualization and performance times, needle tip visualisation and TPVB performance difficulties, number of needle maneuvers, surgical, anesthetic and analgesic follow-up parameters, incidence of postoperative nausea vomiting (PONV), sleep duration, length of postanesthesia care unit (PACU) and hospital stay, patient and surgeon satisfaction scores were all investigated and compared.
Looking for future studies?
Notify Me18 year–65 year
Female
Observational
Aim: The number of obese patients (body mass index (BMI)≥30) has increased dramatically worldwide, and we, as anesthesiologists, routinely come up against them in our daily clinical practice. Although the preference of various peripheral and neuroaxial regional anesthesia (RA) techniques seems to be advantageous in the anesthetic management of these patients, their performances can also be associated with technical difficulties and greater failure rates. The aim of this study is to compare the performance properties and analgesic efficacy of ultrasound (US)-guided thoracic paravertebral blocks (TPVBs) in obese and non-obese patients.
Material methods: After obtaining ethics committee approval; data of 82 patients, who underwent elective bilateral reduction mammaplasty under general anesthesia with adjunctive TPVB analgesia between December of 2016 and February of 2020, were reviewed. Patients were allocated into two groups with respect to their BMI scores (Group NO: BMI<30 and Group O: BMI≥30). Demographics, TPVB ideal US image visualization and performance times, needle tip visualisation and TPVB performance difficulties, number of needle maneuvers, surgical, anesthetic and analgesic follow-up parameters, incidence of postoperative nausea vomiting (PONV), sleep duration, length of postanesthesia care unit (PACU) and hospital stay, patient and surgeon satisfaction scores were all investigated and compared. Student's t, Mann-Whitney-U and Chi-square tests were used for statistical analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The blocks were performed at the T3-T4 level bilaterally to block the dermatomes between the T2 and T6 levels (breast innervation area).
Other names: TPVBs
Time frame: 0-20 minutes
Time period between the US probe placement to the right side at T3-T4 level and the needle withdrawal from the left side T3-T4 level
Time frame: 0-24 hours
NRS pain scores (0: no pain, 10: worst pain imaginable) through postoperative first 24 hours
Time frame: 0-5 minutes
Time period between the US probe placement at T3-T4 level and visualizing the ideal image to perform the block
Time frame: 0-20 minutes
Likert scale: 1-5 (1:very poor, 5:very good)
Time frame: 0-20 minutes
Number of needle maneuvers to reach the paravertebral space (PVS)
Time frame: 0-20 minutes
Requirement of additional needle maneuver due to insufficient local anesthetic (LA) spread
Time frame: 0-20 minutes
Likert scale: 1-5 (1:very poor, 5:very good)
Time frame: 0-1 hours
Modified Aldrete Scoring system (≥9/10)
Time frame: Intraoperative 2-6 hours
If a ≥ 20% increase above preinduction values in MAP or HR was observed during the perioperative period, additional fentanyl dose (1 μg/kg) was applied intravenously.
Time frame: 0-48 hours
Postoperative first pain description (NRS ≥4) until discharge
Time frame: 0-24 hours
Paracetamol was used when postoperative pain NRS ≥4 in the postanesthesia care unit or on the wards (on postoperative day 1)
Time frame: 0-24 hours
Tramadol was used when postoperative pain NRS ≥4 again after 1 hour of paracetamol application in the postanesthesia care unit or on the wards (on postoperative day 1)
Time frame: 0-24 hours
Number of feeling nausea or vomiting
Time frame: 0-24 hours
Total hours of sleep at first night
Time frame: 0-48 hours
Post Anaesthetic Discharge Scoring System (PADSS) (≥9/10)
Time frame: 0-48 hours
Satisfaction score during hospital discharge: 0: very unsatisfied, 3: very satisfied
Time frame: 0-48 hours
Satisfaction score during hospital discharge: 0: very unsatisfied, 3: very satisfied
Istanbul University
Other
The Performance Properties and Efficacy of Ultrasound-Guided Bilateral Thoracic Paravertebral Blocks in Obese and Non-obese Patients Undergoing Reduction Mammaplasty: A Historical Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04787367
Body Weight, Neurologic Manifestations
Clinton Township, Michigan, United States
View Trial DetailsNCT06564610
Agnosia, Analgesia
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT03001843
Body Weight, Laparoscopic Gastric Bypass
Gainesville, Florida, United States
View Trial DetailsNCT03727607
Body Weight, Desflurane
View Trial Details